Simplifying Global Compliance
FDAnews Drug Daily Bulletin
FDA Accepts Medarex Filing to Develop New Cancer Drug
Jan. 30, 2009
Medarex Inc., a biopharmaceutical company … announced that the Food & Drug Administration has accepted its application for an investigational new drug to treat renal cell carcinoma and non-Hodgkin’s lymphoma.
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing